In reading to stay current with industry news and trends, I've become much more familiar with a handful of blogs that I think are well written and researched - and are consistently informative and interesting. I'd like to pass that info along in case readers here have not been fortunate enough to fnd these as well -- although ALL are much better known and read than this site (is or will be).
In no particular order, I will provide links to these blogs and to some of their recent posts of interest to me - you can of course explore each further when you get there.
Eric Milgram writes the Pharma Conduct blog - Straight talk on Big Pharma. He's written extensively in the past couple months on R&D restructuring that is taking place in pharma right now - as companies try to cope with their flaggging pipelines and need to show higher ROI. This link is to an article by Stewart Lyman that examines changes that need to take place. R&D topics have been covered quite well.
Pharma Strategy Blog is written by Sally Church (also uses nom de plume Maverick NY) of Icarus Consultants. The blog focuses on marketing strategy and product development/introduction. Many of the recent posts have focused on oncology topics. This link is to a post on "Why do some companies do well in oncology and others don't?" Enjoy.
Pharma Marketing Blog is written by the well known John Mack. John is prolific, opinionated and always interesting. He gives insider views on a host of topics in pharma - in particular speaks to pharma's marketing of itself. Right now John is posting heavily on changes social media will evoke in pharma marketing. The link provided is to a post on monitoring content on social media (for FDA compliance). John is NOT shy in letting you know where he stands - makes for good reading as a result.
Next on the hit parade, Pharma Tech Talk is the blog of Pharmaceutical Technology. It has several primary authors including Angie Drakulich, Patricia Van Arnum, Erik Greb and Stephanie Sutton (covers EU). The blog covers wide ranging topics in the pharma industry - the link I provided is to a post on RX-360 members sharing quality audit information amongst themselves - or will they?
And finally, the not to be overlooked In the Pipeline by Derek Lowe. Derek comments on drug discovery in particular and the industry in general. He, too, is prolific and provides a wealth of insights and analyses with good opinions. In this case, I linked to a more quirky post to a book recommendation outside the field - what can I say - I like books and the more off the beaten track the better. You can check out Derek's site yourself to discover all the other good stuff he's written about the industry.
That's all she wrote for this morning. I'm off to watch the MVC basketball final between Northern Iowa and Wichita State.
Posted by Bruce Lehr March 7th 2010